-
Open Access Bioinformatics
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Influence of SMAD1 gene in osteoporosis: A bioinformatics approach
Original Research
(1914) Views (508) Full article downloads
Authors: Anand Anabarasu, Arpita Kundu
Published Date July 2010
Volume 2010:2 Pages 79 - 87
DOI: http://dx.doi.org/10.2147/OAB.S12269
Anand Anabarasu, Arpita KunduBioinformatics Division, School of Biosciences and Technology, VIT University, Tamil Nadu, India.
Abstract: In the present study we have analyzed the role of SMAD family member 1 protein (SMAD1) gene products in relation to bone morphogenesis and osteoporosis. Out of 1045 single nucleotide polymorphisms (SNP) investigated, we find that one nonsynonymous SNP (nsSNP), rs1804647, to have significant damaging effects as predicted by all the tools used in the analysis. This nsSNP resulted in a change of amino acid from a positive charged residue, Lysine, to a strong negatively charged residue, Glutamate, and hence the change of residue with opposite charges might lead to structural defects and result in altered function. The results presented in this report will be a good starting point for genetic analysis of SMAD1 genes in patients with osteoporosis which might lead to more conclusive evidence of the association of this gene with osteoporosis.
Keywords: osteoporosis, nsSNP, SMAD1, rs1804647
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Evolution of a domain conserved in microtubule-associated proteins of eukaryotes
- Is gene activity in plant cells affected by UMTS-irradiation? A whole genome approach
- A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells
- Discrimination between biological interfaces and crystal-packing contacts




